Leprêtre F - Search Results

1

Bimodal expression of RHOH during myelomonocytic differentiation: Implications for the expansion of AML differentiation therapy.

Galiègue-Zouitina S, Fu Q, Carton-Latreche C, Poret N, Cheok M, Leprêtre F, Figeac M, Quesnel B, El Bouazzati H, Shelley CS. Galiègue-Zouitina S, et al. Among authors: lepretre f. EJHaem. 2021 Jan 20;2(2):196-210. doi: 10.1002/jha2.128. eCollection 2021 May. EJHaem. 2021. PMID: 35845268 Free PMC article.

2

Sub-clonal analysis of the murine C1498 acute myeloid leukaemia cell line reveals genomic and immunogenic diversity.

Driss V, Leprêtre F, Briche I, Mopin A, Villenet C, Figeac M, Quesnel B, Brinster C. Driss V, et al. Among authors: lepretre f. Immunol Lett. 2017 Dec;192:27-34. doi: 10.1016/j.imlet.2017.10.004. Epub 2017 Oct 10. Immunol Lett. 2017. PMID: 29030252

3

Detection of residual and chemoresistant leukemic cells in an immune-competent mouse model of acute myeloid leukemia: Potential for unravelling their interactions with immunity.

Mopin A, Leprêtre F, Sebda S, Villenet C, Ben Khoud M, Figeac M, Quesnel B, Brinster C. Mopin A, et al. Among authors: lepretre f. PLoS One. 2022 Apr 29;17(4):e0267508. doi: 10.1371/journal.pone.0267508. eCollection 2022. PLoS One. 2022. PMID: 35486629 Free PMC article.

4

p65/RelA NF-κB fragments generated by RIPK3 activity regulate tumorigenicity, cell metabolism, and stemness characteristics.

Touil Y, Latreche-Carton C, Bouazzati HE, Nugues AL, Jouy N, Thuru X, Laine W, Lepretre F, Figeac M, Tardivel M, Kluza J, Idziorek T, Quesnel B. Touil Y, et al. Among authors: lepretre f. J Cell Biochem. 2022 Mar;123(3):543-556. doi: 10.1002/jcb.30198. Epub 2021 Dec 20. J Cell Biochem. 2022. PMID: 34927768 Free PMC article.

5

The stem cell-associated gene expression signature allows risk stratification in pediatric acute myeloid leukemia.

Duployez N, Marceau-Renaut A, Villenet C, Petit A, Rousseau A, Ng SWK, Paquet A, Gonzales F, Barthélémy A, Leprêtre F, Pottier N, Nelken B, Michel G, Baruchel A, Bertrand Y, Leverger G, Lapillonne H, Figeac M, Dick JE, Wang JCY, Preudhomme C, Cheok M. Duployez N, et al. Among authors: lepretre f. Leukemia. 2019 Feb;33(2):348-357. doi: 10.1038/s41375-018-0227-5. Epub 2018 Aug 8. Leukemia. 2019. PMID: 30089916

6

Genomic characterization of Imatinib resistance in CD34+ cell populations from chronic myeloid leukaemia patients.

Joha S, Dauphin V, Leprêtre F, Corm S, Nicolini FE, Roumier C, Nibourel O, Grardel N, Maguer-Satta V, Idziorek T, Figeac M, Laï JL, Quesnel B, Etienne G, Guilhot F, Lippert E, Preudhomme C, Roche-Lestienne C. Joha S, et al. Among authors: lepretre f. Leuk Res. 2011 Apr;35(4):448-58. doi: 10.1016/j.leukres.2010.07.012. Epub 2010 Aug 3. Leuk Res. 2011. PMID: 20684991

7

Isolation and characterization of two canine melanoma cell lines: new models for comparative oncology.

Segaoula Z, Primot A, Lepretre F, Hedan B, Bouchaert E, Minier K, Marescaux L, Serres F, Galiègue-Zouitina S, André C, Quesnel B, Thuru X, Tierny D. Segaoula Z, et al. Among authors: lepretre f. BMC Cancer. 2018 Dec 4;18(1):1219. doi: 10.1186/s12885-018-5114-y. BMC Cancer. 2018. PMID: 30514258 Free PMC article.

8

Expression of CD34 in hematopoietic cancer cell lines reflects tightly regulated stem/progenitor-like state.

Kuranda K, Berthon C, Leprêtre F, Polakowska R, Jouy N, Quesnel B. Kuranda K, et al. Among authors: lepretre f. J Cell Biochem. 2011 May;112(5):1277-85. doi: 10.1002/jcb.23026. J Cell Biochem. 2011. PMID: 21308741

9

Neurofibromatosis-1 gene deletions and mutations in de novo adult acute myeloid leukemia.

Boudry-Labis E, Roche-Lestienne C, Nibourel O, Boissel N, Terre C, Perot C, Eclache V, Gachard N, Tigaud I, Plessis G, Cuccuini W, Geffroy S, Villenet C, Figeac M, Leprêtre F, Renneville A, Cheok M, Soulier J, Dombret H, Preudhomme C; French ALFA group. Boudry-Labis E, et al. Among authors: lepretre f. Am J Hematol. 2013 Apr;88(4):306-11. doi: 10.1002/ajh.23403. Epub 2013 Mar 5. Am J Hematol. 2013. PMID: 23460398 Free article.

10

SNCA locus duplication carriers: from genetics to Parkinson disease phenotypes.

Mutez E, Leprêtre F, Le Rhun E, Larvor L, Duflot A, Mouroux V, Kerckaert JP, Figeac M, Dujardin K, Destée A, Chartier-Harlin MC. Mutez E, et al. Among authors: lepretre f. Hum Mutat. 2011 Apr;32(4):E2079-90. doi: 10.1002/humu.21459. Epub 2011 Feb 8. Hum Mutat. 2011. PMID: 21412942

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page